| NCT03547908 |
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults |
https://ClinicalTrials.gov/show/NCT03547908 |
Recruiting |
Gilead Sciences |
2021-10-31 |
| NCT03252483 |
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department |
https://ClinicalTrials.gov/show/NCT03252483 |
Completed |
New York City Health and Hospitals Corporation |
2013-05-31 |
| NCT03235349 |
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03235349 |
Completed |
AbbVie |
2018-11-15 |
| NCT03222583 |
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03222583 |
Completed |
AbbVie |
2018-10-18 |
| NCT03214679 |
Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) |
https://ClinicalTrials.gov/show/NCT03214679 |
Recruiting |
Weill Medical College of Cornell University |
2021-07-30 |
| NCT03145753 |
Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) |
https://ClinicalTrials.gov/show/NCT03145753 |
Completed |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2017-09-30 |
| NCT03126370 |
Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) |
https://ClinicalTrials.gov/show/NCT03126370 |
Completed |
University of Colorado, Denver |
2019-07-12 |
| NCT03115736 |
TAF for HIV-HBV With Renal Dysfunction |
https://ClinicalTrials.gov/show/NCT03115736 |
Completed |
University Hospital Inselspital, Berne |
2019-12-05 |
| NCT03098121 |
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection |
https://ClinicalTrials.gov/show/NCT03098121 |
Completed |
Taoyuan General Hospital |
2018-11-30 |
| NCT03050905 |
Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B |
https://ClinicalTrials.gov/show/NCT03050905 |
Completed |
HaEmek Medical Center, Israel |
2017-11-16 |
| NCT02938013 |
deLIVER: Direct Acting Antiviral Effects on the Liver |
https://ClinicalTrials.gov/show/NCT02938013 |
Active, not recruiting |
Johns Hopkins University |
2019-09-30 |
| NCT02810275 |
Folinic Acid: Supplementation and Therapy |
https://ClinicalTrials.gov/show/NCT02810275 |
Completed |
Hospital de Clinicas de Porto Alegre |
2013-07-31 |
| NCT02707991 |
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection |
https://ClinicalTrials.gov/show/NCT02707991 |
Completed |
Johns Hopkins University |
2018-04-30 |
| NCT02625909 |
Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. |
https://ClinicalTrials.gov/show/NCT02625909 |
Active, not recruiting |
Kirby Institute |
2020-05-30 |
| NCT04405011 |
NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC |
https://ClinicalTrials.gov/show/NCT04405011 |
Recruiting |
National Taiwan University Hospital |
2020-12-28 |
| NCT02613871 |
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection |
https://ClinicalTrials.gov/show/NCT02613871 |
Completed |
Gilead Sciences |
2017-01-04 |
| NCT02588287 |
Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir |
https://ClinicalTrials.gov/show/NCT02588287 |
Active, not recruiting |
University of Colorado, Denver |
2017-10-31 |
| NCT02555943 |
DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) |
https://ClinicalTrials.gov/show/NCT02555943 |
Recruiting |
Humanity and Health Research Centre |
2020-10-31 |
| NCT02480712 |
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection |
https://ClinicalTrials.gov/show/NCT02480712 |
Completed |
Gilead Sciences |
2016-04-29 |
| NCT02457611 |
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection |
https://ClinicalTrials.gov/show/NCT02457611 |
Completed |
Gilead Sciences |
2016-01-31 |
| NCT02414399 |
Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children |
https://ClinicalTrials.gov/show/NCT02414399 |
Completed |
University of Washington |
2020-05-04 |
| NCT02339337 |
A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection |
https://ClinicalTrials.gov/show/NCT02339337 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2014-06-30 |
| NCT02339038 |
Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia |
https://ClinicalTrials.gov/show/NCT02339038 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-06-15 |
| NCT02294136 |
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection |
https://ClinicalTrials.gov/show/NCT02294136 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-04-28 |
| NCT02281643 |
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana |
https://ClinicalTrials.gov/show/NCT02281643 |
Completed |
Kwame Nkrumah University of Science and Technology |
2017-03-15 |
| NCT02233075 |
REP 2139-Ca / Pegasysâ„¢ Combination Therapy in Hepatitis B / Hepatitis D Co-infection |
https://ClinicalTrials.gov/show/NCT02233075 |
Completed |
Replicor Inc. |
2016-11-30 |
| NCT02178592 |
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection |
https://ClinicalTrials.gov/show/NCT02178592 |
Completed |
ViiV Healthcare |
2017-11-02 |
| NCT02125500 |
Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection |
https://ClinicalTrials.gov/show/NCT02125500 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2015-12-31 |
| NCT02103439 |
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients |
https://ClinicalTrials.gov/show/NCT02103439 |
Completed |
Biocad |
2015-08-26 |
| NCT02073656 |
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection |
https://ClinicalTrials.gov/show/NCT02073656 |
Completed |
Gilead Sciences |
2014-11-30 |
| NCT01900015 |
Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection |
https://ClinicalTrials.gov/show/NCT01900015 |
Completed |
Andaluz Health Service |
2017-01-17 |
| NCT01805258 |
Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB |
https://ClinicalTrials.gov/show/NCT01805258 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2012-12-31 |
| NCT01751555 |
Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection |
https://ClinicalTrials.gov/show/NCT01751555 |
Completed |
National Center for AIDS/STD Control and Prevention, China CDC |
2013-06-30 |
| NCT01747772 |
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01747772 |
Completed |
Massachusetts General Hospital |
2014-02-14 |
| NCT01725542 |
Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders |
https://ClinicalTrials.gov/show/NCT01725542 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2014-04-30 |
| NCT01718301 |
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin |
https://ClinicalTrials.gov/show/NCT01718301 |
Completed |
Fundacion Clinic per a la Recerca Biomédica |
2015-03-31 |
| NCT01707472 |
Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01707472 |
Completed |
Gilead Sciences |
2014-10-17 |
| NCT01557998 |
Testing and Linkage to Care for Injecting Drug Users in Kenya |
https://ClinicalTrials.gov/show/NCT01557998 |
Completed |
Yale University |
2016-04-30 |
| NCT01513941 |
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) |
https://ClinicalTrials.gov/show/NCT01513941 |
Completed |
Janssen-Cilag International NV |
2014-03-31 |
| NCT01335529 |
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin |
https://ClinicalTrials.gov/show/NCT01335529 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2014-05-31 |
| NCT01327547 |
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B |
https://ClinicalTrials.gov/show/NCT01327547 |
Completed |
ViiV Healthcare |
2013-04-23 |
| NCT04382092 |
Co-infection Management in COVID-19 Critically Ill |
https://ClinicalTrials.gov/show/NCT04382092 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2020-04-24 |
| NCT04325438 |
The Impact of Pharmacists’ Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia |
https://ClinicalTrials.gov/show/NCT04325438 |
Completed |
Bekasi City Public Hospital |
2019-02-28 |
| NCT04264130 |
Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection |
https://ClinicalTrials.gov/show/NCT04264130 |
Completed |
Centre de Recherche Médicale de Lambaréné |
2019-12-31 |
| NCT04032860 |
RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection |
https://ClinicalTrials.gov/show/NCT04032860 |
Recruiting |
West China Hospital |
2023-02-10 |
| NCT03797014 |
B/F/TAF Switch Study for HIV-HBV Coinfection |
https://ClinicalTrials.gov/show/NCT03797014 |
Recruiting |
University of Maryland, Baltimore |
2021-02-28 |
| NCT03711721 |
Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa |
https://ClinicalTrials.gov/show/NCT03711721 |
Completed |
University of Washington |
2017-08-31 |
| NCT03646396 |
Effect of Sofosbuvir-daclatasuvir on Angiogenesis |
https://ClinicalTrials.gov/show/NCT03646396 |
Recruiting |
Tanta University |
2025-08-31 |
| NCT03549832 |
Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure |
https://ClinicalTrials.gov/show/NCT03549832 |
Completed |
Assiut University |
2019-01-30 |
| NCT03549312 |
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy |
https://ClinicalTrials.gov/show/NCT03549312 |
Recruiting |
Saskatchewan Health Authority - Regina Area |
2020-07-21 |
| NCT03499639 |
Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease |
https://ClinicalTrials.gov/show/NCT03499639 |
Completed |
Assiut University |
2018-08-01 |
| NCT01222611 |
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir |
https://ClinicalTrials.gov/show/NCT01222611 |
Completed |
Fundacion SEIMC-GESIDA |
2013-06-30 |
| NCT01064947 |
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis |
https://ClinicalTrials.gov/show/NCT01064947 |
Completed |
Derm Research, PLLC |
2012-01-31 |
| NCT00959166 |
To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection |
https://ClinicalTrials.gov/show/NCT00959166 |
Completed |
Imperial College London |
2011-06-30 |
| NCT00879047 |
Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection |
https://ClinicalTrials.gov/show/NCT00879047 |
Completed |
University of California, San Francisco |
2013-04-30 |
| NCT00866021 |
Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r |
https://ClinicalTrials.gov/show/NCT00866021 |
Completed |
Fundacion SEIMC-GESIDA |
2012-06-30 |
| NCT00845676 |
Treatment of Acute Hepatitis C Virus in HIV Co-Infection |
https://ClinicalTrials.gov/show/NCT00845676 |
Completed |
University of California, San Francisco |
2010-12-31 |
| NCT03731559 |
Efficacy, Safety and Pharmacokinetics of DTG With RIF |
https://ClinicalTrials.gov/show/NCT03731559 |
Recruiting |
The HIV Netherlands Australia Thailand Research Collaboration |
2021-06-30 |
| NCT01939197 |
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection |
https://ClinicalTrials.gov/show/NCT01939197 |
Completed |
AbbVie |
2016-07-21 |
| NCT02129244 |
A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes |
https://ClinicalTrials.gov/show/NCT02129244 |
Active, not recruiting |
Johns Hopkins University |
2021-12-31 |
| NCT00686790 |
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) |
https://ClinicalTrials.gov/show/NCT00686790 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-31 |
| NCT00665353 |
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance |
https://ClinicalTrials.gov/show/NCT00665353 |
Completed |
AIDS Clinical Trials Group |
2011-05-31 |
| NCT00507221 |
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression |
https://ClinicalTrials.gov/show/NCT00507221 |
Completed |
University of Washington |
2011-07-31 |
| NCT00476463 |
Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection |
https://ClinicalTrials.gov/show/NCT00476463 |
Completed |
The HIV Netherlands Australia Thailand Research Collaboration |
2008-12-31 |
| NCT00360464 |
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases |
https://ClinicalTrials.gov/show/NCT00360464 |
Completed |
Pfizer |
2007-06-30 |
| NCT00209313 |
Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon |
https://ClinicalTrials.gov/show/NCT00209313 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00192595 |
Tenofovir in HIV/HBV Coinfection |
https://ClinicalTrials.gov/show/NCT00192595 |
Completed |
Kirby Institute |
2007-01-31 |
| NCT00130910 |
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation |
https://ClinicalTrials.gov/show/NCT00130910 |
Completed |
University of Washington |
NA |
| NCT00127959 |
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection |
https://ClinicalTrials.gov/show/NCT00127959 |
Completed |
International Antiviral Therapy Evaluation Center |
NA |
| NCT00015652 |
Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection |
https://ClinicalTrials.gov/show/NCT00015652 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |